Publications by authors named "Matthew Rioth"

Claim this Profile
E
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling.
Jacqueline A Turner, Robert J Van Gulick, William A Robinson, Tariq Mughal, Richard P Tobin, Matthew J Rioth

Int J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Matthew Rioth

J Immunother Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Matthew Rioth

Nat Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Real-World RECIST-based Tumor Response Assessment in Patients With Metastatic Non-small Cell Lung Cancer.
Monika A Izano, Nguyet Tran, Alan Fu, Liz Toland, Danny Idryo, Matthew Rioth

Clin Lung Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.
Michael N Kammer, Dhairya A Lakhani, Aneri B Balar, Sanja L Antic, Amanda K Kussrow, Matthew Rioth

Am J Respir Crit Care Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Customizable Natural Language Processing Biomarker Extraction Tool.
Benjamin Holmes, Dhananjay Chitale, Joshua Loving, Mary Tran, Vinod Subramanian, Matthew Rioth

JCO Clin Cancer Inform· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Mortality Composite Score in the Real-World Setting: Overcoming Source-Specific Disparities and Biases.
Michelle H Lerman, Benjamin Holmes, Daniel St Hilaire, Mary Tran, Matthew Rioth

JCO Clin Cancer Inform· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis.
Xuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, Jess Behrens, Shervin A Etemad, Matthew J Rioth

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
Merve Hasanov, Matthew J Rioth, Kari Kendra, Leonel Hernandez-Aya, Richard W Joseph

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.
Carol M Amato, Jennifer D Hintzsche, Keith Wells, Allison Applegate, Nicholas T Gorden, Matthew Rioth

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
Christina L Aquilante, David P Kao, Katy E Trinkley, Chen-Tan Lin, Kristy R Crooks, Matthew J Rioth

Pharmacogenomics· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Chloe Friedman, Madison Lyon, Robert J Torphy, Daniel Thieu, Patrick Hosokawa, Matthew J Rioth

J Surg Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
Makenzie L Hawkins, Matthew J Rioth, Megan M Eguchi, Myles Cockburn

J Am Acad Dermatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK Inhibitor Response in Melanomas Expressing Fusions and Alternate Isoforms.
Kasey L Couts, Judson Bemis, Jacqueline A Turner, Stacey M Bagby, Danielle Murphy, Matthew J Rioth

Mol Cancer Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Douglas B Johnson, Garrett M Frampton, Matthew J Rioth, Erik Yusko, Yaomin Xu

Cancer Immunol Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care.
Jeremy L Warner, Matthew J Rioth, Kenneth D Mandl, Joshua C Mandel, David A Kreda

J Am Med Inform Assoc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling.
Matthew J Rioth, Ramya Thota, David B Staggs, Douglas B Johnson, Jeremy L Warner

J Am Med Inform Assoc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing and Improving Automated Electronic Tumor Molecular Profiling.
Matthew J Rioth, David B Staggs, Lauren Hackett, Erich Haberman, Mike Tod

J Oncol Pract· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in website information resources to aid in clinical practice.
Matthew J Rioth, Travis J Osterman, Jeremy L Warner

Am Soc Clin Oncol Educ Book· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors in NSCLC.
Douglas B Johnson, Matthew J Rioth, Leora Horn

Curr Treat Options Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
Sandra Ryeom, Kwan-Hyuck Baek, Matthew J Rioth, Ryan C Lynch, Alexander Zaslavsky

Cancer Cell· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium.
Paul Beaudry, Monique Nilsson, Matthew Rioth, Daniela Prox, David Poon

Mol Cancer Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TORC1 is essential for NF1-associated malignancies.
Cory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, Annie W Chan, Elizabeth E Reczek, Matthew J Rioth

Curr Biol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
Sylvie Giuriato, Sandra Ryeom, Alice C Fan, Pavan Bachireddy, Ryan C Lynch, Matthew J Rioth

Proc Natl Acad Sci U S A· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis